GTC Biotherapeutics
ORG
GTC Biotherapeutics GTC
The drug's developer, GTC Biotherapeutics, said it would appeal the decision, adding that the ruling was based mainly on a problem with its clinical trial, not on the fact that the drug was made in goats. GTC and a few other companies put human genes into animals so they produce a human protein in their milk. Other protein drugs, like the one GTC, is developing, are extracted from donated blood, but are found in such minute quantities that they are often in short supply. GTC said it would take 90,000 blood donations to obtain as much of the protein as one of its goats can produce in a year.